Cargando…
Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Autores principales: | Hendlisz, Alain, Golfinopoulos, Vassilis, Deleporte, Amelie, Paesmans, Marianne, El Mansy, Hazem, Garcia, Camilo, Peeters, Marc, Annemans, Lieven, Vandeputte, Caroline, Maetens, Marion, Van den Eynde, Marc, Maréchal, Raphaël, Borbath, Ivan, Dresse, Damien, Houbiers, Ghislain, Fried, Michael, Awada, Ahmad, Piccart, Martine, Van Laethem, Jean-Luc, Flamen, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372227/ https://www.ncbi.nlm.nih.gov/pubmed/25879441 http://dx.doi.org/10.1186/s12885-015-1181-5 |
Ejemplares similares
-
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
por: Hendlisz, Alain, et al.
Publicado: (2013) -
CTCs as a prognostic and predictive biomarker for stage II/III Colon Cancer: a companion study to the PePiTA trial
por: Rothé, Françoise, et al.
Publicado: (2019) -
Correlating tumor metabolic progression index measured by serial FDG PET-CT, apparent diffusion coefficient measured by magnetic resonance imaging (MRI) and blood genomics to patient’s outcome in advanced colorectal cancer: the CORIOLAN study
por: Deleporte, Amelie, et al.
Publicado: (2014) -
The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer
por: Hendlisz, Alain, et al.
Publicado: (2015) -
Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol
por: Hendlisz, Alain, et al.
Publicado: (2015)